-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Measles [Strain Edmonstons-Zagreb] + Rubella [Strain RA-27]) Vaccine in Measles
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Measles [Strain Edmonstons-Zagreb] + Rubella [Strain RA-27]) Vaccine in Measles report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Measles [Strain Edmonstons-Zagreb] + Rubella...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Measles [Strain Edmonstons-Zagreb] + Rubella [Strain RA-27]) Vaccine in Rubella (German Measles)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Measles [Strain Edmonstons-Zagreb] + Rubella [Strain RA-27]) Vaccine in Rubella (German Measles) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Measles [Strain Edmonstons-Zagreb]...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Xanomeline in Alzheimer’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Xanomeline in Alzheimer's Disease report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Xanomeline in Alzheimer's Disease Drug Details: Xanomeline tartrate (LY-246708 tartrate) was...
-
Product Insights
NewSinsin Pharmaceutical Co Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Sinsin Pharmaceutical Co Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Sinsin Pharmaceutical Co Ltd (Sinsin Pharm) is a developer and manufacturer of medical plasters and sanitary aids. The company’s products include pain treatment patches, pain relief sprays, pain relief lotion and cream, hot patches, insect bite products, mosquito repellent, corn removal patches, dandruff removing liniment, cooling pads, head lice removing liniment and wound protection bands among others. Its...
-
Product Insights
NewTeikoku Pharma USA Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Teikoku Pharma USA Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Teikoku Pharma USA Inc (Teikoku Pharma), a subsidiary of Teikoku Seiyaku Co Ltd is a specialty pharmaceutical company that develops and manufactures pharmaceutical products based on its delivery platform technologies in the therapeutic areas of CNS, pain management and oncology. The company offers products such as lidoderm, a prescription, topical, hydrogel patch for post-herpetic neuralgia (PHN) and also...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ND-0612 in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ND-0612 in Parkinson's Disease report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ND-0612 in Parkinson's Disease Drug Details: ND-0612 is under development as...
-
Product Insights
New4P Therapeutics LLC Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our 4P Therapeutics LLC Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. 4P Therapeutics LLC (4P Therapeutics) a subsidiary of NutriBand Inc, is a drug delivery company. The company is engaged in research and development transdermal drug delivery technologies and medicines. Its product pipeline includes scopolamine, follicle stimulating hormone, exenatide, and abuse deterrent fentanyl transdermal systems. It also offers services including chemistry, manufacturing, and controls development, preclinical feasibility, clinical research, manufacturing...
-
Company Insights
NewNeoolife Inc Pipeline Insight and Competitive Landscape, 2024
Empower your strategies with our Neoolife Inc Pipeline Insight and Competitive Landscape, 2024 report and make more profitable business decisions. Neoolife Inc is a medical equipment manufacturing company engaged in designing, production, marketing of tissue-engineered biomimetic heart valves and cardiovascular patches. The company is headquartered in Pittsburgh, Pennsylvania, the US. GlobalData's Medical Devices company profile report, “Neoolife Inc Pipeline Insight and Competitive Landscape, 2024" provides information about the company overview and analysis on their pipeline products. This company profile report...
-
Product Insights
Likelihood of Approval Analysis for Kaposi Sarcoma
Overview How likely is it that the drugs in Kaposi Sarcoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Kaposi Sarcoma Overview Kaposi's sarcoma is a cancer that causes patches of...
-
Product Insights
Likelihood of Approval Analysis for Alopecia Areata
Overview How likely is it that the drugs in Alopecia Areata will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Alopecia Areata Overview Alopecia areata is an autoimmune condition characterized by unpredictable,...